These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24375558)

  • 21. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
    Siebert JD; McClure SP; Banks PM; Gulley ML
    Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The immunophenotype in leukemia].
    Pizzolo G; Vinante F; Benedetti F; Vincenzi C; Morosato L; De Sabata D
    Haematologica; 1991 Jun; 76 Suppl 3():19-25. PubMed ID: 1752513
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathology of malignant lymphomas.
    Kadin ME; Said JW
    Curr Opin Oncol; 1990 Oct; 2(5):822-31. PubMed ID: 1965694
    [No Abstract]   [Full Text] [Related]  

  • 25. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
    Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
    Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD20-positive adult T-cell leukemia.
    Yasukawa M; Arai J; Kakimoto M; Sakai I; Kohno H; Fujita S
    Am J Hematol; 2001 Jan; 66(1):39-41. PubMed ID: 11426490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
    Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
    Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.
    Rahemtullah A; Reichard KK; Preffer FI; Harris NL; Hasserjian RP
    Am J Clin Pathol; 2006 Nov; 126(5):805-14. PubMed ID: 17050078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nodular lymphocyte predominant Hodgkin lymphoma. An immunophenotypic reappraisal based on a single-institution experience.
    Uherova P; Valdez R; Ross CW; Schnitzer B; Finn WG
    Am J Clin Pathol; 2003 Feb; 119(2):192-8. PubMed ID: 12579988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
    Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
    J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
    von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
    Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
    Churchill HR; Roncador G; Warnke RA; Natkunam Y
    Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunohistochemistry of Hodgkin's disease.
    Said JW
    Semin Diagn Pathol; 1992 Nov; 9(4):265-71. PubMed ID: 1362283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Success in chemotherapy of cancer. The curing of Hodgkin's disease. II].
    Lopez M
    Clin Ter; 2000; 151(5):375-82. PubMed ID: 11141723
    [No Abstract]   [Full Text] [Related]  

  • 35. Hodgkin lymphoma with cutaneous involvement.
    Hsia CC; Howson-Jan K; Rizkalla KS
    Dermatol Online J; 2009 May; 15(5):5. PubMed ID: 19624983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease.
    Zukerberg LR; Collins AB; Ferry JA; Harris NL
    Am J Pathol; 1991 Sep; 139(3):475-83. PubMed ID: 1716042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
    Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
    J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.
    Echeverri C; Fisher S; King D; Craig FE
    Am J Clin Pathol; 2002 Apr; 117(4):615-20. PubMed ID: 11939737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.